Connect the evidence.
Move your research forward.
Explore companies, publications, and developments across focused areas of drug development. Turn a scientific question into a clearer next step.
Focused fields. Connected research.
Therapeutic Platforms
Explore developers and research by technology and payload.
Oral cyclic peptides
This guide separates oral cyclic peptide drug programs from formulation, delivery, and manufacturing services. Start by checking the molecule's structural class and site of action, then compare the evidence supporting its oral development strategy.
Companies · News · PublicationsProtein degradation / PROTAC
This guide organizes companies and updates by PROTACs, molecular glue degraders, and other degradation approaches. Use the target, lead program, and development stage to distinguish mechanistic research, clinical development, and services offered to clients.
Companies · News · PublicationsmRNA / LNP
This guide separates RNA products, LNP delivery platforms, and development and manufacturing services. Compare the RNA type, target tissue, study stage, and process and analytical capabilities rather than treating a platform label as evidence of performance.
Companies · News · PublicationsOligonucleotide Therapeutics & Delivery
Follow siRNA, ASOs, splice modulation, conjugation, delivery, analytics, and manufacturing.
Research questions & evidence boundariesIn Vivo Cell Engineering & Gene Editing
Explore in vivo CAR-T, nonviral editing delivery, cell targeting, and relevant measurement methods.
Research questions & evidence boundariesDevelopment & Measurement
Find methods, evidence, and partners for practical development questions.
Formulation Development & Manufacturing
This guide spans preformulation, dosage forms, delivery approaches, and clinical and commercial manufacturing. Define the molecule's development challenge and project stage before checking which experiments, scale-up, transfer, and manufacturing activities a provider can perform.
Companies · News · PublicationsPharmaceutical solid state
This guide connects polymorph, salt, and cocrystal screening with crystallization, solid-state characterization, and structure determination. When reading a study or selecting a partner, identify the solid-state question first, then assess whether the method and deliverable support the project decision.
Companies · News · PublicationsMicroED structure determination
This guide covers pharmaceutical-relevant MicroED and three-dimensional electron diffraction services, platforms, and research. Distinguish structure determination services from instrument supply and partner-delivered work, then check the sample type and disclosed methods before assessing fit.
Companies · News · PublicationsBiologics Characterization & CMC Analytics
Explore analytical evidence for structure, heterogeneity, potency, and comparability.
Research questions & evidence boundariesBioanalysis & Biomarkers
Connect measurement strategy and interpretation across PK/TK, immunogenicity, and biomarkers.
Research questions & evidence boundariesClinical Pharmacology & Model-Informed Development
Organize clinical pharmacology and modeling around exposure, response, and dose decisions.
Research questions & evidence boundariesCompanies & Markets
Distinguish developers, technology platforms, and service providers using original disclosures.
China-listed CRO/CDMO
This guide groups listed companies by clinical research, preclinical work, drug discovery, CDMO services, and mixed businesses. Before comparing results, confirm the listed entity, consolidation boundary, and reporting period, then examine revenue, earnings, and cash flow together.
Companies · News · PublicationsFind relevant companies
Browse public profiles, then filter, compare, and save companies in the member workspace.
Build your research workspace
Organize company tags, interactions, and private notes, and export your research.
Keep the research that matters to you.
Read public research to discover information. Use your member workspace to compare companies, save findings, and manage your own interaction records.